224 related articles for article (PubMed ID: 4603404)
1. [Clinical studies on Ovostat--a combined oral contraceptive with a low dose of lynestrenol].
Rice-Wray E; Cervantes A
Geburtshilfe Frauenheilkd; 1974 May; 34(5):380-3. PubMed ID: 4603404
[TBL] [Abstract][Full Text] [Related]
2. [Experience with a low dosage ovulation inhibitor].
Himmelsbach H
Med Monatsschr; 1969 Dec; 23(12):561-3. PubMed ID: 5387171
[TBL] [Abstract][Full Text] [Related]
3. Ovanon. A new sequential oral contraceptive.
Rice-Wray E; Peña A; Maqueo M
Int J Fertil; 1968; 13(4):453-9. PubMed ID: 5700405
[No Abstract] [Full Text] [Related]
4. [Clinical study of a mestranol lynestrenol combination of 1 mg. (preliminary report)].
Mateos Cándano M; Bolio Arizta R
Ginecol Obstet Mex; 1969 Jun; 25(152):647-53. PubMed ID: 5372809
[TBL] [Abstract][Full Text] [Related]
5. [Clinical study of a new oral contraceptive: ovostat].
Callaerts J; Demol R; Figoureux J; Kock E; Huyghebaert G
Brux Med; 1973 Jul; 53(7):409-18. PubMed ID: 4582059
[TBL] [Abstract][Full Text] [Related]
6. [Clinico-pathological study of the effects of contraceptive treatment with mestranol-lynestrol by a sequential type method].
Arrizabalaga Amarelo R; Rojas M; Corral Gallardo J
Ginecol Obstet Mex; 1972 Apr; 31(186):419-32. PubMed ID: 5028610
[TBL] [Abstract][Full Text] [Related]
7. A new oral contraceptive with a 7 plus 15 sequential formulation.
Brosens I; Van Assche A; Wijnants P
Arzneimittelforschung; 1970 Feb; 20(2):236-7. PubMed ID: 5467468
[No Abstract] [Full Text] [Related]
8. [Ovostat, a low dose oral contraceptive].
Linthorst G; Wolff J
Brux Med; 1970 Jun; 50(6):433-7. PubMed ID: 5487467
[No Abstract] [Full Text] [Related]
9. [Trial of a new low-dose anti-ovulation contraceptive].
Bayot D
Schweiz Rundsch Med Prax; 1970 Apr; 59(16):593-7. PubMed ID: 5519719
[No Abstract] [Full Text] [Related]
10. A modified sequential contraceptive.
Rice-Wray E; Gorodovsky J; Peña A
Contraception; 1972 Jun; 5(6):457-72. PubMed ID: 4119579
[No Abstract] [Full Text] [Related]
11. Clinical evaluation of a normophasic oral contraceptive.
Notelovitz M
S Afr Med J; 1973 Oct; 47(41):1943-7. PubMed ID: 4748659
[No Abstract] [Full Text] [Related]
12. [Clinical trial of a combined oral contraceptive with low estrogen dose (author's transl)].
Schmidt-Elmendorff HW
MMW Munch Med Wochenschr; 1975 Feb; 117(9):345-8. PubMed ID: 804642
[TBL] [Abstract][Full Text] [Related]
13. Oestrogen content of oral contraceptives and thromboembolism.
McQueen EG
N Z Med J; 1970 May; 71(456):317. PubMed ID: 5270982
[No Abstract] [Full Text] [Related]
14. [Effects of lynestrenol used singly in low doses, as a contraceptive].
Rubio Lotvin B; Ruiz Moreno JA; Bolio Arista R; Meza y Gutiérrez E; González Ansorena R
Ginecol Obstet Mex; 1975 Jun; 37(224):365-74. PubMed ID: 1100481
[TBL] [Abstract][Full Text] [Related]
15. Oral contraceptives according to the normophasic principle.
Borglin NE; Klottrup P
Arzneimittelforschung; 1978; 28(12):2354-7. PubMed ID: 582954
[TBL] [Abstract][Full Text] [Related]
16. [Clinical study of a new, normophasic type oral contraceptive].
Dombrowicz N
Brux Med; 1973 Dec; 53(12):747-55. PubMed ID: 4778356
[TBL] [Abstract][Full Text] [Related]
17. [Results with the new ovulation inhibitor Ovostat].
Lohmeyer H; Loch EG
Praxis; 1969 Oct; 58(40):1266-71. PubMed ID: 5394570
[No Abstract] [Full Text] [Related]
18. Rationale for a triphasic oral contraceptive.
Pasquale SA
J Reprod Med; 1984 Jul; 29(7 Suppl):560-7. PubMed ID: 6481710
[TBL] [Abstract][Full Text] [Related]
19. Anovulatory effect of lynestrenol in combination with mestranol.
Knutsson F; Rybo G; Anberg A
Acta Obstet Gynecol Scand; 1965; 44(2):325-38. PubMed ID: 5834181
[No Abstract] [Full Text] [Related]
20. [Experiences with the normophasic ovulation inhibitor Ovanon].
Nadjafi C
Schweiz Z Gynakol Geburtshilfe; 1971; 2(3):237-44. PubMed ID: 12276413
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
